Reckitt Benckiser Group (LON:RKT – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at Citigroup in a research note issued on Wednesday, MarketBeat.com reports. They currently have a GBX 7,000 price objective on the stock. Citigroup’s target price points to a potential upside of 13.40% from the company’s previous close.
A number of other brokerages have also recently commented on RKT. Deutsche Bank Aktiengesellschaft upped their price target on shares of Reckitt Benckiser Group from GBX 5,600 to GBX 5,700 and gave the company a “buy” rating in a research report on Friday, October 24th. UBS Group reaffirmed a “buy” rating and set a GBX 7,700 target price on shares of Reckitt Benckiser Group in a research note on Friday, October 17th. Royal Bank Of Canada lowered Reckitt Benckiser Group to a “sector perform” rating and dropped their price target for the company from GBX 6,400 to GBX 6,200 in a research note on Wednesday. Jefferies Financial Group raised their price objective on shares of Reckitt Benckiser Group from GBX 5,500 to GBX 5,700 and gave the stock a “hold” rating in a research report on Wednesday, January 7th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Reckitt Benckiser Group from GBX 5,500 to GBX 6,100 and gave the company a “neutral” rating in a research report on Wednesday, November 26th. Three research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, Reckitt Benckiser Group currently has an average rating of “Hold” and a consensus target price of GBX 6,279.29.
Read Our Latest Stock Analysis on Reckitt Benckiser Group
Reckitt Benckiser Group Trading Down 0.2%
Insiders Place Their Bets
In other Reckitt Benckiser Group news, insider Patricia Verduin acquired 135 shares of the stock in a transaction on Wednesday, October 29th. The shares were purchased at an average price of GBX 5,867 per share, for a total transaction of £7,920.45. Insiders own 0.42% of the company’s stock.
About Reckitt Benckiser Group
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
See Also
- Five stocks we like better than Reckitt Benckiser Group
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- If You Keep Cash In A U.S. Bank Account… Read This NOW
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
